Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes

NCT02315495 is registered in ClinicalTrials.gov with Zilin Sun as lead sponsor.

NCT NCT02315495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02315495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes
Lead sponsor
Zilin Sun
Phase
Phase 3
Overall status
Completed
Start date
April 3, 2015
Completion date
August 26, 2016
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes